Carrying Rare Cures Across Miles

https://delivery-p55671-e392469.adobeaemcloud.com/adobe/assets/urn:aaid:aem:64d03579-9131-45fa-977e-316ec7863c6a/as/blog-carryingcuresovermiles-header-image.avif?assetname=blog-carryingcuresovermiles-header-image.png

UPS Healthcare • May 25, 2025 • 8-minute read

From fragile doses to saved lives, discover the logistics bringing rare disease cures to those in need.

Author: Lalitha Garidi Product Management

When Every Dose Counts

When we talk about vaccines, we usually think of public health campaigns, mass immunizations, and global-scale cold-chain networks. But there’s another side to the story—one that doesn’t often make headlines: vaccines for rare diseases.

These are the therapies developed for the few, not the many. They’re often lifesaving, always time-sensitive, and rarely built for mass production.

And while the science behind them is groundbreaking, there’s one simple truth that holds everything together: if the vaccine doesn’t arrive on time and in perfect condition, it doesn’t work.

As someone who supports UPS Healthcare’s go-to-market strategy, I spend a lot of time immersed in these behind-the-scenes challenges. And the more I’ve learned, the more I’ve realized just how fragile the link is between scientific progress and patient outcomes—especially when temperature control is involved.

Let’s talk about that.

Why Logistics Matters

image of doctor caring for child patient

While rare diseases are, by definition, uncommon—each affecting fewer than 200,000 people in the U.S.—they collectively affect over 30 million Americans1 and more than 400 million globally2. These patients are often children, and many are waiting for therapies that didn’t even exist a decade ago.

The vaccine pipeline for rare diseases is offering a new hope. With the introduction of groundbreaking technologies like gene-based and mRNA platforms, it’s now possible to target conditions that were considered untreatable3. That’s the good news.

The Challenges

These vaccines are highly sensitive to environmental conditions—especially temperature.

That’s not a theoretical statistic. That’s doses lost. Lives disrupted. And for vaccines with narrow distribution windows and small patient populations, every single shipment counts.

The challenges go beyond refrigeration. Rare disease vaccines often cross countries with varying regulations, infrastructure, and climates.

Delivering rare disease vaccines safely and on time isn’t just about solving logistical issues—it’s about saving lives, advancing research, and ensuring every dose counts.

A Real-World Example

premier stories video

Earlier this year, a shipment bound for a hospital in the Midwest hit a familiar but formidable obstacle: a winter storm. The package carried a newly approved rare disease vaccine for an adolescent patient and had been assigned UPS® Premier Silver by the shipper— a company that provides commercial support and logistics services for pharmaceutical and biotechnology manufacturers.

The assigned Healthcare Recovery Agent began actively monitoring the package the moment weather alerts came in. As snow halted movement in multiple states, the package was flagged for delay. Attempts to reach operations were initially met with long hold times. But the urgency was clear—this wasn’t just a missed delivery window. It was a missed treatment milestone.

The Healthcare Recovery Agent escalated the case to the UPS Healthcare Command Center, tracked the package through several facilities, and eventually coordinated with local teams to secure a same-day courier pickup. After over 100 minutes of persistent coordination—including calls, re-routing, and real-time visibility tracking—the vaccine was delivered.

On time. At temperature. Viable.

It wasn’t just a logistical win. It was a real-world example of what it means to protect a dose that could change a life.

How This Works

There’s no magic here—just a deeply integrated, sensor-driven supply chain supported by UPS Healthcare trained professionals.

With UPS® Premier  service, packages aren’t just scanned—they’re actively monitored in near real-time, with sensors that track both location and condition. That visibility enables:

What’s most important is this: the system isn’t just built to know when there’s a problem. It’s built to respond.

image of scientist in lab working on experiment

One trend I’ve been watching closely—and I know many of our customers are too—is the rise of ultra-specialized vaccine production.

In a post-pandemic world, mRNA and nucleic acid-based vaccines have unlocked the ability to personalize vaccine design. That means smaller, more targeted batches shipped to specific patients, sometimes even through clinical trial pathways.4 The implication? The supply chain must be as precise and specialized as the science.

We’re not just talking about temperature anymore—we’re talking about:

And it’s not just happening in developed markets. We’re seeing this model expand into Latin America, Eastern Europe, and parts of Asia, where infrastructure limitations make these shipments even more complex—and more vital.

Lessons from the Field

Working in healthcare logistics has taught me a few truths:

img-left

https://delivery-p55671-e392469.adobeaemcloud.com/adobe/assets/urn:aaid:aem:05b8687e-3b64-44bb-b28a-56dbb42110f4/as/blog-carryingcuresacrossmiles-tile-image4.avif?assetname=blog-carryingcuresacrossmiles-tile-image4.png

  • Every vaccine has a story.

    Even when it’s not going to millions, it’s going to someone who needs it.
  • Recovery doesn’t mean failure—it means resilience.

    Delays happen. What matters is how we respond.
  • Empathy matters.

    Behind every shipment is a parent, a pharmacist, a physician who just wants the therapy to arrive intact.

And maybe the biggest lesson of all: logistics isn’t separate from care. It is care.

A Look Ahead

At UPS Healthcare, we’re continuing to invest in the systems and services that rare disease vaccines require:

We’re also preparing for the next wave of small-batch therapies, personalized vaccines, and clinical trial accelerators. Because the future of care isn’t just faster—it’s more tailored, and the supply chain needs to rise to meet it.

In Summary

image of ups truck driving on the road

In a world full of automation and AI, it’s easy to forget that healthcare logistics still comes down to people making the right call at the right time. A recovery agent who refuses to hang up. A facility manager who opens the trailer one last time. A courier who quietly says, “I’ve got it.”

For rare disease vaccine delivery, those moments are everything.

At UPS Healthcare, we’re proud to be a quiet but essential part of those life-changing stories. We’re not the scientists. We’re not the clinicians. But we are the ones making sure the science reaches the people who need it—on time, intact, and ready to heal.

Sources:

  1. Rare Diseases at FDA | FDA
  2. Rare Disease Day 2022: The Evolving Impact of Genomics and Precision Health | Blogs | CDC
  3. Why optimized cold-chains could save a billion COVID vaccines
  4. Rare diseases the next target for mRNA therapies